Skip to main content

Advertisement

SpringerLink
Log in

Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The aim of this study is to investigate the associations between E-cadherin gene (CDH1) polymorphisms and papillary thyroid carcinoma (PTC) risk predisposition. We undertook a case–control study to analyze three CDH1 polymorphisms (+54T>C, −160C>A, and −347G→GA) in an Han Chinese population, by extraction of genomic DNA from the peripheral blood of 98 patients with PTC and 176 control participants, and performed CDH1 genotyping using DNA sequencing. The obtained results indicated that overall, no statistically significant association was observed in +54T>C. Nevertheless, −347G→GA genotype was at increased risk of PTC (P = 0.001; odds ratio (OR) = 2.12, CI 95%:1.24–3.34). Furthermore, −347GA/GA genotype thyroid cancers were more significantly common in patients with tumor size of ≥20 mm than G or G/GA genotypes PTC and in cases of advanced T stage. However, −160C>A genotype demonstrated a protective effect in PTCs (P = 0.006; OR = 0.59, CI 95%: 0.42–0.87). These findings led us to conclude that polymorphism in −347G→GA was observed to be associated with susceptibility of PTC. However, −160C>A polymorphism indicated to play a protective role in susceptibility to PTC. Nevertheless, further investigation with a larger sample size is needed to support our results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Y.E. Nikiforov, Is ionizing radiation responsible for the increasing incidence of thyroid cancer? Cancer 116(7), 1626–1628 (2010). doi:10.1002/cncr.24889

    Article  PubMed  Google Scholar 

  2. L. Hegedus, Clinical practice. The thyroid nodule. N. Engl. J. Med. 351(17), 1764–1771 (2004). doi:10.1056/NEJMcp031436

    Article  PubMed  Google Scholar 

  3. R. Paschke, K.W. Schmid, R. Gartner, K. Mann, H. Dralle, C. Reiners, Epidemiology, pathophysiology, guideline-adjusted diagnostics, and treatment of thyroid nodules. Med. Klin. (Munich) 105(2), 80–87 (2010). doi:10.1007/s00063-010-1011-9

    Article  Google Scholar 

  4. D.S. Dean, H. Gharib, Epidemiology of thyroid nodules. Best Pract. Res. Clin. Endocrinol. Metab. 22(6), 901–911 (2008). doi:10.1016/j.beem.2008.09.019

    Article  PubMed  Google Scholar 

  5. C. Martinez-Rico, F. Pincet, J.P. Thiery, S. Dufour, Integrins stimulate E-cadherin-mediated intercellular adhesion by regulating Src-kinase activation and actomyosin contractility. J. Cell Sci. 123(Pt 5), 712–722 (2010). doi:10.1242/jcs.047878

    Article  PubMed  CAS  Google Scholar 

  6. J. Kucharczak, S. Charrasse, F. Comunale, J. Zappulla, B. Robert, I. Teulon-Navarro, A. Pelegrin, C. Gauthier-Rouviere, R-Cadherin expression inhibits myogenesis and induces myoblast transformation via Rac1 GTPase. Cancer Res. 68(16), 6559–6568 (2008). doi:10.1158/0008-5472.CAN-08-0196

    Article  PubMed  CAS  Google Scholar 

  7. S.C. Suzuki, M. Takeichi, Cadherins in neuronal morphogenesis and function. Dev. Growth Differ. 1(50 Suppl), S119–S130 (2008). doi:10.1111/j.1440-169X.2008.01002.x

    Article  Google Scholar 

  8. H.C. Chen, R.Y. Chu, P.N. Hsu, P.I. Hsu, J.Y. Lu, K.H. Lai, H.H. Tseng, N.H. Chou, M.S. Huang, C.J. Tseng, M. Hsiao, Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett. 201(1), 97–106 (2003)

    Article  PubMed  CAS  Google Scholar 

  9. U. Cavallaro, G. Christofori, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4(2), 118–132 (2004)

    Article  PubMed  CAS  Google Scholar 

  10. K.S. Nadella, G.N. Jones, A. Trimboli, C.A. Stratakis, G. Leone, L.S. Kirschner, Targeted deletion of Prkar1a reveals a role for protein kinase A in mesenchymal-to-epithelial transition. Cancer Res. 68(8), 2671–2677 (2008). doi:10.1158/0008-5472.CAN-07-6002

    Article  PubMed  CAS  Google Scholar 

  11. A. Mitselou, E. Ioachim, D. Peschos, K. Charalabopoulos, M. Michael, N.J. Agnantis, T. Vougiouklakis, E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. Exp Oncol 29(1), 54–60 (2007)

    PubMed  CAS  Google Scholar 

  12. E. Brecelj, S. Frkovic Grazio, M. Auersperg, M. Bracko, Prognostic value of E-cadherin expression in thyroid follicular carcinoma. Eur. J. Surg. Oncol. 31(5), 544–548 (2005). doi:10.1016/j.ejso.2005.02.003

    Article  PubMed  CAS  Google Scholar 

  13. A.S. Rocha, P. Soares, E. Fonseca, J. Cameselle-Teijeiro, M.C. Oliveira, M. Sobrinho-Simoes, E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology 42(6), 580–587 (2003)

    Article  PubMed  CAS  Google Scholar 

  14. G. Serini, L. Trusolino, E. Saggiorato, O. Cremona, M. De Rossi, A. Angeli, F. Orlandi, P.C. Marchisio, Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J. Natl. Cancer Inst. 88(7), 442–449 (1996)

    Article  PubMed  CAS  Google Scholar 

  15. P. Soares, G. Berx, F. van Roy, M. Sobrinho-Simoes, E-cadherin gene alterations are rare events in thyroid tumors. Int. J. Cancer 70(1), 32–38 (1997). doi:10.1002/(SICI)1097-0215(19970106)70:1<32:AID-IJC5>3.0.CO;2-7

    Article  PubMed  CAS  Google Scholar 

  16. A.S. Rocha, P. Soares, R. Seruca, V. Maximo, X. Matias-Guiu, J. Cameselle-Teijeiro, M. Sobrinho-Simoes, Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J. Pathol. 194(3), 358–366 (2001). doi:10.1002/path.905

    Article  PubMed  CAS  Google Scholar 

  17. A. Nakamura, T. Shimazaki, K. Kaneko, M. Shibata, T. Matsumura, M. Nagai, R. Makino, K. Mitamura, Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat. Res. 502(1–2), 19–24 (2002)

    PubMed  CAS  Google Scholar 

  18. Y. Shin, I.J. Kim, H.C. Kang, J.H. Park, H.R. Park, H.W. Park, M.A. Park, J.S. Lee, K.A. Yoon, J.L. Ku, J.G. Park, The E-cadherin −347G>GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 25(6), 895–899 (2004). doi:10.1093/carcin/bgh073

    Article  PubMed  Google Scholar 

  19. L.C. Li, R.M. Chui, M. Sasaki, K. Nakajima, G. Perinchery, H.C. Au, D. Nojima, P. Carroll, R. Dahiya, A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 60(4), 873–876 (2000)

    PubMed  CAS  Google Scholar 

  20. H. Yamada, K. Shinmura, S. Ikeda, H. Tao, T. Otani, T. Hanaoka, T. Tsuneyoshi, S. Tsugane, H. Sugimura, Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand. J. Gastroenterol. 42(12), 1479–1485 (2007). doi:10.1080/00365520701478436

    Article  PubMed  CAS  Google Scholar 

  21. L. Gao, A. Nieters, H. Brenner, Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility. Aliment. Pharmacol. Ther. 28(5), 565–573 (2008). doi:10.1111/j.1365-2036.2008.03760.x

    Article  PubMed  CAS  Google Scholar 

  22. S.B. Edge, American Joint Committee on Cancer: AJCC Cancer Staging Manual, 7th edn. (Springer, New York, 2010)

    Google Scholar 

  23. F. van Roy, G. Berx, The cell–cell adhesion molecule E-cadherin. Cell. Mol. Life Sci. 65(23), 3756–3788 (2008). doi:10.1007/s00018-008-8281-1

    Article  PubMed  CAS  Google Scholar 

  24. S. Baranwal, S.K. Alahari, Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem. Biophys. Res. Commun. 384(1), 6–11 (2009). doi:10.1016/j.bbrc.2009.04.051

    Article  PubMed  CAS  Google Scholar 

  25. A. Jeanes, C.J. Gottardi, A.S. Yap, Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27(55), 6920–6929 (2008). doi:10.1038/onc.2008.343

    Article  PubMed  CAS  Google Scholar 

  26. H.J. Martens, V. Geenen, Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer. Endocrine 13(3), 233–242 (2000). doi:10.1385/ENDO:13:3:233

    Article  PubMed  CAS  Google Scholar 

  27. F. Cattaneo, T. Venesio, S. Molatore, A. Russo, R. Fiocca, M. Frattini, A.I. Scovassi, L. Ottini, L. Bertario, G.N. Ranzani, Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk. Anticancer Res. 26(6B), 4627–4632 (2006)

    PubMed  CAS  Google Scholar 

  28. X.F. Zhang, Y.M. Wang, H. Ge, Y.Y. Cao, Z.F. Chen, D.G. Wen, W. Guo, N. Wang, Y. Li, J.H. Zhang, Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus 21(1), 21–29 (2008). doi:10.1111/j.1442-2050.2007.00724.x

    PubMed  Google Scholar 

  29. M.S. Al-Moundhri, M. Al-Khanbashi, M. Al-Kindi, M. Al-Nabhani, I.A. Burney, A. Al-Farsi, B. Al-Bahrani, Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J. Gastroenterol. 16(27), 3432–3436 (2010)

    Article  PubMed  CAS  Google Scholar 

  30. B. Zhang, K. Pan, Z. Liu, J. Zhou, L. Gu, J. Ji, J. Ma, W.C. You, D. Deng, Genetic polymorphisms of the E-cadherin promoter and risk of sporadic gastric carcinoma in Chinese populations. Cancer Epidemiol. Biomarkers Prev. 17(9), 2402–2408 (2008). doi:10.1158/1055-9965.EPI-08-0315

    Article  PubMed  CAS  Google Scholar 

  31. J.G. Kim, Y.S. Chae, S.K. Sohn, Y.Y. Cho, J.H. Moon, J.Y. Park, S.W. Jeon, I.T. Lee, G.S. Choi, S.H. Jun, Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin. Cancer Res. 14(1), 62–66 (2008). doi:10.1158/1078-0432.CCR-07-1537

    Article  PubMed  CAS  Google Scholar 

  32. H. Tsukino, Y. Kuroda, H. Nakao, H. Imai, H. Inatomi, K. Kohshi, Y. Osada, T. Katoh, E-cadherin gene polymorphism and risk of urothelial cancer. Cancer Lett. 195(1), 53–58 (2003)

    Article  PubMed  CAS  Google Scholar 

  33. M.S. Wu, S.P. Huang, Y.T. Chang, M.T. Lin, C.T. Shun, M.C. Chang, H.P. Wang, C.J. Chen, J.T. Lin, Association of the -160 C–&gt; a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 94(5), 1443–1448 (2002). doi:10.1002/cncr.10371

    Article  PubMed  CAS  Google Scholar 

  34. J.C. Yu, H.M. Hsu, S.T. Chen, G.C. Hsu, C.S. Huang, M.F. Hou, Y.P. Fu, T.C. Cheng, P.E. Wu, C.Y. Shen, Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility. J. Biomed. Sci. 13(3), 419–432 (2006). doi:10.1007/s11373-006-9069-7

    Article  PubMed  CAS  Google Scholar 

  35. H. Lei, S. Sjoberg-Margolin, S. Salahshor, B. Werelius, E. Jandakova, K. Hemminki, A. Lindblom, I. Vorechovsky, CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int. J. Cancer 98(2), 199–204 (2002). doi:10.1002/ijc.10176

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Dr Jun Zhang for his valuable comments during the conception of this study. In addition, the authors gratefully acknowledge the support provided by Dr Hai-Bo Xue for this study. Funding for this study was obtained from the Binzhou Medical University Foundation.

Conflicts of interest

There are no any actual or potential conflicts of interest exist.

Author information

Authors and Affiliations

  1. Department of Endocrinology, School of Clinical Medicine, Binzhou Medical University, No. 661, Yellow-River Second Street, Binzhou, 256603, China

    Ying-Xue Wang, Xiu-Yun Wang, Chang-Mei Liu & Su-Guo Yu

  2. Department of Radiotherapy, Cancer Center, Sun Yat-Sen University, Guangzhou, China

    Lei Zhao

  3. State Key Laboratory of Oncology in Southern China, Cancer Center, Sun Yat-Sen University, Guangzhou, China

    Lei Zhao

Authors
  1. Ying-Xue Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiu-Yun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chang-Mei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Su-Guo Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ying-Xue Wang.

Additional information

Ying-Xue Wang and Lei Zhao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, YX., Zhao, L., Wang, XY. et al. Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population. Endocrine 41, 526–531 (2012). https://doi.org/10.1007/s12020-011-9582-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-011-9582-y

Keywords

Search

Navigation